Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis

Digital measures of health status captured during daily life could greatly augment current in-clinic assessments for rheumatoid arthritis (RA), to enable better assessment of disease progression and impact. This work presents results from weaRAble-PRO, a 14-day observational study, which aimed to in...

Full description

Bibliographic Details
Main Authors: Creagh, AP, Hamy, V, Yuan, H, Mertes, G, Tomlinson, R, Chen, W-H, Williams, R, Llop, C, Yee, C, Duh, MS, Doherty, A, Garcia-Gancedo, L, Clifton, DA
Format: Journal article
Language:English
Published: Springer Nature 2024
_version_ 1811139166180737024
author Creagh, AP
Hamy, V
Yuan, H
Mertes, G
Tomlinson, R
Chen, W-H
Williams, R
Llop, C
Yee, C
Duh, MS
Doherty, A
Garcia-Gancedo, L
Clifton, DA
author_facet Creagh, AP
Hamy, V
Yuan, H
Mertes, G
Tomlinson, R
Chen, W-H
Williams, R
Llop, C
Yee, C
Duh, MS
Doherty, A
Garcia-Gancedo, L
Clifton, DA
author_sort Creagh, AP
collection OXFORD
description Digital measures of health status captured during daily life could greatly augment current in-clinic assessments for rheumatoid arthritis (RA), to enable better assessment of disease progression and impact. This work presents results from weaRAble-PRO, a 14-day observational study, which aimed to investigate how digital health technologies (DHT), such as smartphones and wearables, could augment patient reported outcomes (PRO) to determine RA status and severity in a study of 30 moderate-to-severe RA patients, compared to 30 matched healthy controls (HC). Sensor-based measures of health status, mobility, dexterity, fatigue, and other RA specific symptoms were extracted from daily iPhone guided tests (GT), as well as actigraphy and heart rate sensor data, which was passively recorded from patients’ Apple smartwatch continuously over the study duration. We subsequently developed a machine learning (ML) framework to distinguish RA status and to estimate RA severity. It was found that daily wearable sensor-outcomes robustly distinguished RA from HC participants (F1, 0.807). Furthermore, by day 7 of the study (half-way), a sufficient volume of data had been collected to reliably capture the characteristics of RA participants. In addition, we observed that the detection of RA severity levels could be improved by augmenting standard patient reported outcomes with sensor-based features (F1, 0.833) in comparison to using PRO assessments alone (F1, 0.759), and that the combination of modalities could reliability measure continuous RA severity, as determined by the clinician-assessed RAPID-3 score at baseline (r2, 0.692; RMSE, 1.33). The ability to measure the impact of the disease during daily life—through objective and remote digital outcomes—paves the way forward to enable the development of more patient-centric and personalised measurements for use in RA clinical trials.
first_indexed 2024-09-25T04:01:46Z
format Journal article
id oxford-uuid:6d395064-a68f-4a34-9515-7e4665cadf6a
institution University of Oxford
language English
last_indexed 2024-09-25T04:01:46Z
publishDate 2024
publisher Springer Nature
record_format dspace
spelling oxford-uuid:6d395064-a68f-4a34-9515-7e4665cadf6a2024-04-26T12:56:21ZDigital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6d395064-a68f-4a34-9515-7e4665cadf6aEnglishSymplectic ElementsSpringer Nature2024Creagh, APHamy, VYuan, HMertes, GTomlinson, RChen, W-HWilliams, RLlop, CYee, CDuh, MSDoherty, AGarcia-Gancedo, LClifton, DADigital measures of health status captured during daily life could greatly augment current in-clinic assessments for rheumatoid arthritis (RA), to enable better assessment of disease progression and impact. This work presents results from weaRAble-PRO, a 14-day observational study, which aimed to investigate how digital health technologies (DHT), such as smartphones and wearables, could augment patient reported outcomes (PRO) to determine RA status and severity in a study of 30 moderate-to-severe RA patients, compared to 30 matched healthy controls (HC). Sensor-based measures of health status, mobility, dexterity, fatigue, and other RA specific symptoms were extracted from daily iPhone guided tests (GT), as well as actigraphy and heart rate sensor data, which was passively recorded from patients’ Apple smartwatch continuously over the study duration. We subsequently developed a machine learning (ML) framework to distinguish RA status and to estimate RA severity. It was found that daily wearable sensor-outcomes robustly distinguished RA from HC participants (F1, 0.807). Furthermore, by day 7 of the study (half-way), a sufficient volume of data had been collected to reliably capture the characteristics of RA participants. In addition, we observed that the detection of RA severity levels could be improved by augmenting standard patient reported outcomes with sensor-based features (F1, 0.833) in comparison to using PRO assessments alone (F1, 0.759), and that the combination of modalities could reliability measure continuous RA severity, as determined by the clinician-assessed RAPID-3 score at baseline (r2, 0.692; RMSE, 1.33). The ability to measure the impact of the disease during daily life—through objective and remote digital outcomes—paves the way forward to enable the development of more patient-centric and personalised measurements for use in RA clinical trials.
spellingShingle Creagh, AP
Hamy, V
Yuan, H
Mertes, G
Tomlinson, R
Chen, W-H
Williams, R
Llop, C
Yee, C
Duh, MS
Doherty, A
Garcia-Gancedo, L
Clifton, DA
Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis
title Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis
title_full Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis
title_fullStr Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis
title_full_unstemmed Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis
title_short Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis
title_sort digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis
work_keys_str_mv AT creaghap digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT hamyv digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT yuanh digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT mertesg digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT tomlinsonr digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT chenwh digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT williamsr digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT llopc digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT yeec digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT duhms digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT dohertya digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT garciagancedol digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis
AT cliftonda digitalhealthtechnologiesandmachinelearningaugmentpatientreportedoutcomestoremotelycharacteriserheumatoidarthritis